Sari Atula

3.0k total citations
55 papers, 1.6k citations indexed

About

Sari Atula is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Sari Atula has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 14 papers in Neurology. Recurrent topics in Sari Atula's work include Multiple Sclerosis Research Studies (14 papers), Acute Ischemic Stroke Management (10 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers). Sari Atula is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Acute Ischemic Stroke Management (10 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers). Sari Atula collaborates with scholars based in Finland, United States and United Kingdom. Sari Atula's co-authors include Stina Syrjänen, Reidar Grénman, Daniel Strbian, Merja Soilu‐Hänninen, Atte Meretoja, P. Laippala, Jukka Putaala, Jaakko Nevalainen, Olli Häppölä and Ville Artto and has published in prestigious journals such as Journal of Clinical Oncology, Stroke and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Sari Atula

52 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sari Atula Finland 21 501 459 374 298 277 55 1.6k
Thomas M. Zizic United States 24 545 1.1× 237 0.5× 279 0.7× 192 0.6× 207 0.7× 31 2.8k
Elisenda Grivé Spain 16 115 0.2× 512 1.1× 915 2.4× 773 2.6× 279 1.0× 28 1.7k
Christopher S. Graffeo United States 24 209 0.4× 925 2.0× 178 0.5× 975 3.3× 224 0.8× 271 2.7k
Masahiro Izumi Japan 25 328 0.7× 71 0.2× 154 0.4× 87 0.3× 142 0.5× 73 2.1k
Joseph M. Hoxworth United States 19 157 0.3× 146 0.3× 101 0.3× 400 1.3× 103 0.4× 68 1.5k
Takashi Yamaki Japan 24 108 0.2× 167 0.4× 110 0.3× 310 1.0× 121 0.4× 134 1.9k
Kesava Reddy Canada 21 32 0.1× 578 1.3× 239 0.6× 973 3.3× 230 0.8× 73 2.1k
John Henley United States 27 240 0.5× 220 0.5× 156 0.4× 441 1.5× 371 1.3× 85 2.0k
Bülent Yalçın Türkiye 20 304 0.6× 92 0.2× 94 0.3× 101 0.3× 280 1.0× 144 1.2k
Meral Çalgünerı Türkiye 31 378 0.8× 258 0.6× 346 0.9× 91 0.3× 594 2.1× 98 3.2k

Countries citing papers authored by Sari Atula

Since Specialization
Citations

This map shows the geographic impact of Sari Atula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari Atula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari Atula more than expected).

Fields of papers citing papers by Sari Atula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sari Atula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari Atula. The network helps show where Sari Atula may publish in the future.

Co-authorship network of co-authors of Sari Atula

This figure shows the co-authorship network connecting the top 25 collaborators of Sari Atula. A scholar is included among the top collaborators of Sari Atula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari Atula. Sari Atula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laakso, Sini M., et al.. (2025). Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria—a nationwide population-based registry study over five decades. Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(1). 3120689373–3120689373. 2 indexed citations
2.
Laakso, Sini M., et al.. (2025). Mortality and causes of death for people with multiple sclerosis: a Finnish nationwide register study. Journal of Neurology. 272(5). 370–370. 2 indexed citations
3.
Piehl, Fredrik, John Vissing, Juha Mehtälä, et al.. (2024). Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population‐based registry study. European Journal of Neurology. 31(12). e16511–e16511. 3 indexed citations
4.
Atula, Sari, et al.. (2023). Frequency and risk factors of rebound after fingolimod discontinuation – A retrospective study. Multiple Sclerosis and Related Disorders. 81. 105134–105134. 9 indexed citations
5.
Atula, Sari, et al.. (2023). A skewed ratio of free light chains is more common in patients with late-onset than early-onset myasthenia gravis. Immunology Letters. 260. 81–88. 2 indexed citations
6.
Martola, Juha, et al.. (2023). Incidental demyelination in magnetic resonance imaging and 10‐year risk of multiple sclerosis: A data lake cohort study. European Journal of Neurology. 30(8). 2376–2384. 1 indexed citations
7.
Atula, Sari, et al.. (2022). Ectopic germinal centers in the thymus accurately predict prognosis of myasthenia gravis after thymectomy. Modern Pathology. 35(9). 1168–1174. 15 indexed citations
8.
Laakso, Sini M., et al.. (2021). Comorbidities worsen the prognosis of generalized myasthenia gravis post-thymectomy. Journal of the Neurological Sciences. 427. 117549–117549. 18 indexed citations
9.
Kauppi, Juha, Sari Atula, Daniel Strbian, et al.. (2020). Improvement in symptom remission rate following robotic thymectomy in patients with myasthenia gravis. Interactive Cardiovascular and Thoracic Surgery. 30(6). 827–833. 5 indexed citations
10.
Saraste, Maija, Sari Atula, Klaus Hedman, et al.. (2018). Humoral response to John Cunningham virus during pregnancy in multiple sclerosis. Multiple Sclerosis and Related Disorders. 21. 11–18. 3 indexed citations
11.
Atula, Sari, et al.. (2016). Gender differences in the clinical course of Finnish gelsolin amyloidosis. Amyloid. 23(1). 33–38. 8 indexed citations
12.
Strbian, Daniel, et al.. (2015). Natural course of Finnish gelsolin amyloidosis. Annals of Medicine. 47(6). 506–511. 39 indexed citations
13.
Tienari, Pentti J., et al.. (2013). Neuromyelitis optica and aquaporin‐4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland. Acta Ophthalmologica. 92(4). 387–391. 12 indexed citations
14.
Soilu‐Hänninen, Merja, Julia Åivo, Irina Elovaara, et al.. (2012). A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 83(5). 565–571. 208 indexed citations
15.
Mustanoja, Satu, Atte Meretoja, Jukka Putaala, et al.. (2010). Outcome by Stroke Etiology in Patients Receiving Thrombolytic Treatment. Stroke. 42(1). 102–106. 78 indexed citations
16.
Lees, Kennedy R., Gary A. Ford, Keith W. Muir, et al.. (2008). Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM. 101(11). 863–869. 43 indexed citations
17.
Atula, Sari. (2000). Mental disorders due to somatic disease.
18.
Atula, Sari, Reidar Grénman, Harry Kujari, & Stina Syrjänen. (1999). Detection of human papillomavirus (HPV) in laryngeal carcinoma cell lines provides evidence for a heterogeneic cell population. European Journal of Cancer. 35(5). 825–832. 22 indexed citations
19.
Atula, Sari, Reidar Grénman, & Stina Syrjänen. (1997). Fibroblasts Can Modulate the Phenotype of Malignant Epithelial Cellsin Vitro. Experimental Cell Research. 235(1). 180–187. 64 indexed citations
20.
Atula, Sari, Kaisa Kurvinen, Reidar Grénman, & Stina Syrjänen. (1996). SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer. European Journal of Cancer Part B Oral Oncology. 32(4). 222–229. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026